drugset / Trial / NCT04964414
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
This research study is a randomized controlled trial in pediatric and young adult patients who have lost their sense of smell due to COVID-19 viral infection. The goals are: 1. to learn more about the effects of smell retraining therapy on smell loss following COVID-19 and 2. to determine if budesonide-saline irrigations make smell retraining therapy more effective.
Timeline
- Start
- 2021-09-30
- Primary completion
- 2023-01-13
- Completion
- 2023-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 0.5 mg | Other |